Nasdaq smmt.
Phunware Inc (NASDAQ:PHUN)’s Major holders Insiders own 8.46% of the company shares, while shares held by institutions stand at 9.60% with a share float percentage of 10.48%. Investors are also buoyed by the number of investors in a company, with Phunware Inc having a total of 43 institutions that hold shares in the company.
Should You Buy or Sell Summit Therapeutics Stock? Get The Latest SMMT Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at ...OXFORD, United Kingdom, April 28, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript 11 Stocks with Heavy Insider Buying in 2023 Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2022 Earnings Call Transcript 25 ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Oxford, UK, and Cambridge, MA, US, September 17, 2020 – Summit Therapeutics plc (NASDAQ: SMMT) led by billionaire investor Robert W. Duggan as Executive Chairman, Chief Executive Officer and ...
May 22, 2023 · Summit Therapeutics PLC (NASDAQ:SMMT)’s CEO Robert Duggan also bought a 376 million shares of the company during the same month at $1.05 per share. As of May 19, the stock is trading at $1.62. Interactive Chart for Summit Therapeutics Inc. (SMMT), analyze all the data with a huge range of indicators.
CAMBRIDGE, Mass. and OXFORD, United Kingdom, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for ...WebSummit Therapeutics Inc. Common Stock (SMMT) Analyst Research | Nasdaq in the last 3 months. The average price target is Sign in to your SmartPortfolio to see more analyst …BABA. 73.60. -1.71%. 19.59M. New. View today's Summit Therapeutics PLC stock price and latest SMMT news and analysis. Create real-time notifications to follow any changes in …Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Cambridge, MA, November 23, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Mahkam “Maky” Zanganeh, DDS, MBA, has been appointed as Chief Operating Officer, effective ...
Oxford, UK, and Cambridge, MA, US, 3 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it presented results from the Phase 2 clinical trial of ridinilazole in ...
Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...Nasdaq. 14,305.03 +78.81 ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have ...Oxford, UK, and Cambridge, MA, US, 5 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) presented in vivo proof of concept data for its targeted Enterobacteriaceae antibiotics in ...NASDAQ: SMMT Summit Therapeutics. Market Cap. $1B. Today's Change (0.54%) $0.01. ... Shares of Summit Therapeutics (SMMT 0.54%), a clinical-stage biopharmaceutical company, tanked Monday morning ...Nasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 …
SMMT Summit Therapeutics Inc Form PRE 14A - Other preliminary proxy statements. ... (NASDAQ:SMMT) Historical Stock Chart From Oct 2023 to Nov 2023 Summit Therapeutics (NASDAQ:SMMT)Dec 20, 2021 · Cambridge, MA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced topline results for the Phase III Ri-CoDIFy study ... May 11, 2023 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK. View live Summit Therapeutics Inc. chart to track its stock's price action. Find market predictions, SMMT financials and market news. Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started. Outsmart the market with Smart Portfolio analytical tools powered …
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ...
OXFORD, United Kingdom, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ...About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Tesla, Inc. Common Stock. $204.99 -16.73 7.55%.Complete Summit Therapeutics Inc. stock information by Barron's. View real-time SMMT stock price and news, along with industry-best analysis.The company earned $0.27 million during the quarter. Summit Therapeutics has generated ($1.55) earnings per share over the last year ( ($1.55) diluted earnings per share). Summit Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior ...The company earned $0.27 million during the quarter. Summit Therapeutics has generated ($1.55) earnings per share over the last year ( ($1.55) diluted earnings per share). Summit Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior ...Follow. Cambridge, MA, May 18, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) announced today that it has selected a new preclinical candidate, SMT026738 (“SMT-738”), for development in the ...By way of example, Summit Therapeutics (NASDAQ:SMMT) has seen its share price rise 106% over the last year, delighting many shareholders. Having said that, unprofitable companies are risky because ...Nasdaq provides company’s , which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all publicly ... Avenue Therapeutics Inc (NASDAQ:ATXI)’s Major holders. Insiders own 18.50% of the company shares, while shares held by institutions stand at 9.14% with a share float percentage of 11.21%. Investors are also buoyed by the number of investors in a company, with Avenue Therapeutics Inc having a total of 17 institutions that hold shares …Web
Simply Wall St. Insider Monkey. Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing.
NASDAQ: SMMT Summit Therapeutics. Market Cap. $1B. Today's Change (0.54%) $0.01. ... Shares of Summit Therapeutics (SMMT 0.54%), a clinical-stage biopharmaceutical company, tanked Monday morning ...
Oxford, UK, and Cambridge, MA, US, 18 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced the publication of a Personal Perspective entitled “Combating ...Oxford, UK, and Cambridge, MA, US, 14 April 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that Mr Robert (Bob) Duggan has been appointed Chief Executive Officer (‘CEO’) of ...Jan 30, 2023 · MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ... Nasdaq 14,241.02 –0.07% Crude Oil 75.26 +0.53% US 10 Yr 100.83 +2,191.72% Euro 1.10 +0.04% Dow Jones 35,333.47 –0.16% Russell 2000 1,801.15Nov 18, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT) trade information. Upright in the green during last session for gaining 3.76%, in the last five days SMMT remained trading in the green while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $1.93 price level, adding 5.85% to its value on the day. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics Inc. Common Stock (SMMT) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. 11 de mai. de 2023 ... (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the ...(NASDAQ:SMMT) insiders must be dismayed to see the company's market cap drop to US$1.2b. (Simply Wall St.) May-16-23 01:21PM · Why Shares of Summit ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.
Oxford, UK, and Cambridge, MA, US, 15 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, presented in vivo proof of concept data for ...View live Summit Therapeutics Inc. chart to track its stock's price action. Find market predictions, SMMT financials and market news.Summit Therapeutics Inc Ordinary Shares SMMT Morningstar Rating Unlock Stock XNAS Rating as of Dec 1, 2023 Summary Chart News Price vs Fair Value …Instagram:https://instagram. pimco high yield municipal bond fundascent solar stockc3.ai stock forecast 2025apps to invest in real estate Summit Therapeutics PLC (NASDAQ:SMMT)’s CEO Robert Duggan also bought a 376 million shares of the company during the same month at $1.05 per share. As of May 19, the stock is trading at $1.62. kevin murphy salon locatorsnap amazon Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ... ticker orcl Dec 6, 2022 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.